BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35364590)

  • 1. Early repeat resection for residual glioblastoma: decision-making among an international cohort of neurosurgeons.
    Kim AA; Dono A; Khalafallah AM; Nettel-Rueda B; Samandouras G; Hadjipanayis CG; Mukherjee D; Esquenazi Y
    J Neurosurg; 2022 Dec; 137(6):1618-1627. PubMed ID: 35364590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.
    Sonabend AM; Zacharia BE; Cloney MB; Sonabend A; Showers C; Ebiana V; Nazarian M; Swanson KR; Baldock A; Brem H; Bruce JN; Butler W; Cahill DP; Carter B; Orringer DA; Roberts DW; Sagher O; Sanai N; Schwartz TH; Silbergeld DL; Sisti MB; Thompson RC; Waziri AE; Ghogawala Z; McKhann G
    Neurosurgery; 2017 Apr; 80(4):590-601. PubMed ID: 27509070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
    Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
    J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When gross total resection of a glioblastoma is possible, how much resection should be achieved?
    Chaichana KL; Cabrera-Aldana EE; Jusue-Torres I; Wijesekera O; Olivi A; Rahman M; Quinones-Hinojosa A
    World Neurosurg; 2014; 82(1-2):e257-65. PubMed ID: 24508595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.
    Orringer D; Lau D; Khatri S; Zamora-Berridi GJ; Zhang K; Wu C; Chaudhary N; Sagher O
    J Neurosurg; 2012 Nov; 117(5):851-9. PubMed ID: 22978537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial biopsy and early re-resection practices in the treatment of glioblastoma among AANS/CNS tumor section surgeons.
    Baron RB; Kessler RA; Hadjipanayis CG
    J Neurooncol; 2019 Sep; 144(3):529-534. PubMed ID: 31368054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of the neurosurgeons estimation of extent of resection in glioblastoma.
    Sezer S; van Amerongen MJ; Delye HHK; Ter Laan M
    Acta Neurochir (Wien); 2020 Feb; 162(2):373-378. PubMed ID: 31656985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
    Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
    J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
    Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
    Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.
    Kuhnt D; Becker A; Ganslandt O; Bauer M; Buchfelder M; Nimsky C
    Neuro Oncol; 2011 Dec; 13(12):1339-48. PubMed ID: 21914639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
    Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
    Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions.
    Müller DMJ; Robe PA; Ardon H; Barkhof F; Bello L; Berger MS; Bouwknegt W; Van den Brink WA; Conti Nibali M; Eijgelaar RS; Furtner J; Han SJ; Hervey-Jumper SL; Idema AJS; Kiesel B; Kloet A; Mandonnet E; De Munck JC; Rossi M; Sciortino T; Vandertop WP; Visser M; Wagemakers M; Widhalm G; Witte MG; Zwinderman AH; De Witt Hamer PC
    J Neurosurg; 2022 Jan; 136(1):45-55. PubMed ID: 34243150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.
    Lau D; Hervey-Jumper SL; Han SJ; Berger MS
    J Neurosurg; 2018 May; 128(5):1410-1418. PubMed ID: 28731401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision making and surgical modality selection in glioblastoma patients: an international multicenter survey.
    Gerritsen JKW; Broekman MLD; De Vleeschouwer S; Schucht P; Jungk C; Krieg SM; Nahed BV; Berger MS; Vincent AJPE
    J Neurooncol; 2022 Feb; 156(3):465-482. PubMed ID: 35067847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.
    Chaichana KL; Jusue-Torres I; Navarro-Ramirez R; Raza SM; Pascual-Gallego M; Ibrahim A; Hernandez-Hermann M; Gomez L; Ye X; Weingart JD; Olivi A; Blakeley J; Gallia GL; Lim M; Brem H; Quinones-Hinojosa A
    Neuro Oncol; 2014 Jan; 16(1):113-22. PubMed ID: 24285550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
    Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
    Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudoprogression in glioblastoma patients: the impact of extent of resection.
    Park HH; Roh TH; Kang SG; Kim EH; Hong CK; Kim SH; Ahn SS; Lee SK; Choi HJ; Cho J; Kim SH; Lee KS; Suh CO; Chang JH
    J Neurooncol; 2016 Feb; 126(3):559-66. PubMed ID: 26608521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic estimation of extent of resection and residual tumor volume of patients with glioblastoma.
    Meier R; Porz N; Knecht U; Loosli T; Schucht P; Beck J; Slotboom J; Wiest R; Reyes M
    J Neurosurg; 2017 Oct; 127(4):798-806. PubMed ID: 28059651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.